These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 15047034)

  • 1. The management of anticoagulants in the periendoscopic period for patients with atrial fibrillation: a decision analysis.
    Gerson LB; Triadafilopoulos G; Gage BF
    Am J Med; 2004 Apr; 116(7):451-9. PubMed ID: 15047034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect and outcomes of the ASGE guidelines on the periendoscopic management of patients who take anticoagulants.
    Gerson LB; Gage BF; Owens DK; Triadafilopoulos G
    Am J Gastroenterol; 2000 Jul; 95(7):1717-24. PubMed ID: 10925974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative management of patients on oral anticoagulants: a decision analysis.
    Dunn AS; Wisnivesky J; Ho W; Moore C; McGinn T; Sacks HS
    Med Decis Making; 2005; 25(4):387-97. PubMed ID: 16061890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
    Douketis JD; Johnson JA; Turpie AG
    Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding.
    Douketis JD; Arneklev K; Goldhaber SZ; Spandorfer J; Halperin F; Horrow J
    Arch Intern Med; 2006 Apr; 166(8):853-9. PubMed ID: 16636210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin.
    Kovacs MJ; Kearon C; Rodger M; Anderson DR; Turpie AG; Bates SM; Desjardins L; Douketis J; Kahn SR; Solymoss S; Wells PS
    Circulation; 2004 Sep; 110(12):1658-63. PubMed ID: 15364803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation.
    Hylek EM; Skates SJ; Sheehan MA; Singer DE
    N Engl J Med; 1996 Aug; 335(8):540-6. PubMed ID: 8678931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of genotype-guided warfarin therapy for anticoagulation in elderly patients with atrial fibrillation.
    Leey JA; McCabe S; Koch JA; Miles TP
    Am J Geriatr Pharmacother; 2009 Aug; 7(4):197-203. PubMed ID: 19766951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: The appropriate use and barriers to oral anticoagulant therapy.
    Partington SL; Abid S; Teo K; Oczkowski W; O'Donnell MJ
    Thromb Res; 2007; 120(5):663-9. PubMed ID: 17434577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low molecular weight heparin versus unfractionated heparin in the colonoscopy peri-procedure period: a cost modeling study.
    Goldstein JL; Larson LR; Yamashita BD; Fain JM; Schumock GT
    Am J Gastroenterol; 2001 Aug; 96(8):2360-6. PubMed ID: 11513175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative anticoagulation in patients with chronic atrial fibrillation who are undergoing elective surgery: results of a physician survey.
    Douketis JD; Crowther MA; Cherian SS
    Can J Cardiol; 2000 Mar; 16(3):326-30. PubMed ID: 10744795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should hemodialysis patients with atrial fibrillation undergo systemic anticoagulation? A cost-utility analysis.
    Quinn RR; Naimark DM; Oliver MJ; Bayoumi AM
    Am J Kidney Dis; 2007 Sep; 50(3):421-32. PubMed ID: 17720521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Out of hospital antithrombotic prophylaxis after total hip replacement: low-molecular-weight heparin, warfarin, aspirin or nothing? A cost-effectiveness analysis.
    Sarasin FP; Bounameaux H
    Thromb Haemost; 2002 Apr; 87(4):586-92. PubMed ID: 12008939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation.
    Hylek EM; Evans-Molina C; Shea C; Henault LE; Regan S
    Circulation; 2007 May; 115(21):2689-96. PubMed ID: 17515465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anticoagulation treatment in real-life practice of patient with nonvalvular atrial fibrillation in Beijing city].
    Zuo HJ; Su JL; Zeng H; Yuan BH; Yao CH
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(33):2328-31. PubMed ID: 18036295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Warfarin is not needed in low-risk patients following atrial fibrillation ablation procedures.
    Bunch TJ; Crandall BG; Weiss JP; May HT; Bair TL; Osborn JS; Anderson JL; Lappe DL; Muhlestein JB; Nelson J; Allison S; Foley T; Anderson L; Day JD
    J Cardiovasc Electrophysiol; 2009 Sep; 20(9):988-93. PubMed ID: 19473299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose warfarin in atrial fibrillation leads to more thromboembolic events without reducing major bleeding when compared to adjusted-dose--a meta-analysis.
    Perret-Guillaume C; Wahl DG
    Thromb Haemost; 2004 Feb; 91(2):394-402. PubMed ID: 14961170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of anticoagulation control and costs of monitoring warfarin therapy among patients with atrial fibrillation in clinic settings: a multi-site managed-care study.
    Menzin J; Boulanger L; Hauch O; Friedman M; Marple CB; Wygant G; Hurley JS; Pezzella S; Kaatz S
    Ann Pharmacother; 2005 Mar; 39(3):446-51. PubMed ID: 15701783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.